Gail Cawkwell

Insider Reports History

Entity
Individual
Location
C/O Aclaris Therapeutics, Inc., 640 Lee Road, Suite 200, Wayne, PA
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gail Cawkwell:

Stock Role Class Num Shares Value Price $ Report Date Ownership
INTERCEPT PHARMACEUTICALS, INC. SVP, Med Affairs, Safety & PV Common Stock 35.7K $679K $19.00 Feb 12, 2022 Direct
Aclaris Therapeutics, Inc. Chief Medical Officer Restricted Stock Units 45K $47.3K $1.05 Jul 1, 2023 Direct
Aclaris Therapeutics, Inc. Chief Medical Officer Common Stock 9.59K $10.1K $1.05 Jul 1, 2023 Direct
INTERCEPT PHARMACEUTICALS, INC. SVP, Med Affairs, Safety & PV Option to Purchase Common Stock 11.3K Jan 27, 2022 Direct

Insider Reports Filed by Gail Cawkwell

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACRS Aclaris Therapeutics, Inc. Jul 1, 2023 3 -$56.1K 4 Jul 5, 2023 Chief Medical Officer
ACRS Aclaris Therapeutics, Inc. Feb 1, 2023 2 $0 4 Feb 3, 2023 Chief Medical Officer
ACRS Aclaris Therapeutics, Inc. Jul 1, 2022 2 $0 4 Jul 5, 2022 Chief Medical Officer
ACRS Aclaris Therapeutics, Inc. Jun 27, 2022 0 $0 3 Jul 5, 2022 Chief Medical Officer
ICPT INTERCEPT PHARMACEUTICALS, INC. Feb 12, 2022 1 -$5.06K 4 Feb 15, 2022 SVP, Med Affairs, Safety & PV
ICPT INTERCEPT PHARMACEUTICALS, INC. Jan 27, 2022 2 $0 4 Jan 31, 2022 SVP, Med Affairs, Safety & PV
ICPT INTERCEPT PHARMACEUTICALS, INC. Dec 31, 2021 1 -$40K 4 Jan 4, 2022 SVP, Med Affairs, Safety & PV
ICPT INTERCEPT PHARMACEUTICALS, INC. Nov 12, 2021 1 -$6.07K 4 Nov 16, 2021 SVP, Med Affairs, Safety & PV
ICPT INTERCEPT PHARMACEUTICALS, INC. Aug 12, 2021 1 -$4.87K 4 Aug 13, 2021 SVP, Med Affairs, Safety & PV
ICPT INTERCEPT PHARMACEUTICALS, INC. May 12, 2021 1 -$5.66K 4 May 13, 2021 SVP, Med Affairs, Safety & PV